We are live on ! Find out more
NVO

Novo Nordisk

431 hedge funds and large institutions have $6.47B invested in Novo Nordisk in 2013 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 181 increasing their positions, 122 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 181 | Existing positions reduced: 122

45% more funds holding in top 10

Funds holding in top 10: 1116 (+5)

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

18% more call options, than puts

Call options by funds: $39M | Put options by funds: $33M

1% more funds holding

Funds holding: 425431 (+6)

3% more capital invested

Capital invested by funds: $6.26B → $6.47B (+$210M)

1.17% less ownership

Funds ownership: 83.35%82.19% (-1.2%)

Holders
431
Holders Change
+6
Holders Change %
+1.41%
% of All Funds
12.51%
Holding in Top 10
16
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+45.45%
% of All Funds
0.46%
New
52
Increased
181
Reduced
122
Closed
41
Calls
$39M
Puts
$33M
Net Calls
+$6.01M
Net Calls Change
+$700K
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
101
Autus Asset Management
Arizona
$5.16M +$19.5M +1,120,790 +406%
WAM
102
World Asset Management
Michigan
$5.13M -$1.62M -93,080 -25%
MIS
103
Morningstar Investment Services
Illinois
$5.07M +$1.12M +64,200 +31%
RMDI
104
R.M. Davis Inc
Maine
$4.94M +$2.22M +127,450 +91%
FA
105
FDx Advisors
Illinois
$4.89M +$18.2M +1,045,470 +396%
TNB
106
Thomasville National Bank
Georgia
$4.72M +$852K +48,870 +24%
HL
107
HeadInvest LLC
Maine
$4.71M -$102K -5,850 -2%
PM
108
Penbrook Management
New York
$4.69M +$4.43M +254,000 New
CW
109
Cobiz Wealth
Colorado
$4.61M -$92.5K -5,310 -2%
BFM
110
Boston Financial Management
Massachusetts
$4.54M +$124K +7,100 +3%
GF
111
Goodman Financial
Texas
$4.44M -$99.7K -5,720 -2%
SB
112
Suntrust Banks
Georgia
$4.16M +$68.5K +3,930 +2%
PA
113
Pinnacle Associates
New York
$4.15M +$894K +51,270 +30%
Parnassus Investments
114
Parnassus Investments
California
$4.07M +$1.22M +70,000 +47%
PCM
115
Palisade Capital Management
New Jersey
$4.05M +$52.3K +3,000 +1%
AA
116
AlphaMark Advisors
Kentucky
$3.96M -$133K -7,620 -3%
SAM
117
Silvercrest Asset Management
New York
$3.89M +$477K +27,380 +15%
CK
118
Carnick & Kubik
Colorado
$3.8M +$3.58M +205,550 New
DA
119
Dillon & Associates
Michigan
$3.78M +$185K +10,600 +5%
SAM
120
Sectoral Asset Management
Quebec, Canada
$3.72M +$61K +3,500 +2%
TD Asset Management
121
TD Asset Management
Ontario, Canada
$3.7M +$68.5K +3,930 +2%
LPL Financial
122
LPL Financial
California
$3.7M +$452K +25,950 +15%
FMT
123
First Mercantile Trust
Tennessee
$3.67M +$168K +9,650 +5%
TAM
124
Trillium Asset Management
Massachusetts
$3.6M -$1.86M -106,940 -35%
Barclays
125
Barclays
United Kingdom
$3.55M +$1.61M +92,270 +92%

NVO Hedge Fund Activity: Q4 2013 in Review

431 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2013, worth a combined $6.47B — up 3.4% from $6.26B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new NVO positions and 41 closed out — a net gain of 11 holders — while 181 added to existing stakes and 122 trimmed.

The largest buyer was WCM Investment Management, adding an estimated $143M. The largest seller was Ameriprise, cutting an estimated $205M.

  • 431 institutional investors held Novo Nordisk (NVO) as of Q4 2013, up from 425 in Q3 2013.
  • Funds reported $6.47B of Novo Nordisk stock for Q4 2013, up 3.4% quarter-over-quarter.
  • 52 funds opened new Novo Nordisk positions in Q4 2013 and 41 closed out, a net change of +11 holders.
  • The largest Novo Nordisk buyer in Q4 2013 was WCM Investment Management, an estimated $143M added.
  • The largest Novo Nordisk seller in Q4 2013 was Ameriprise, an estimated $205M sold.

Based on aggregated 13F filings for Q4 2013.